𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Osteoprotegerin in the Inner Ear May Inhibit Bone Remodeling in the Otic Capsule

✍ Scribed by Andreas F. Zehnder; Arthur G. Kristiansen; Joe C. Adams; Saumil N. Merchant; Michael J. McKenna


Book ID
110087551
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
822 KB
Volume
115
Category
Article
ISSN
0023-852X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The tyrosine kinase inhibitor dasatinib
✍ Kate Vandyke; Andrea L Dewar; Peter Diamond; Stephen Fitter; Christopher G Schul πŸ“‚ Article πŸ“… 2010 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 423 KB

## Abstract Dasatinib is a potent tyrosine kinase inhibitor that is used to treat chronic myeloid leukemia in patients resistant or intolerant to imatinib mesylate. While designed to inhibit Abl and Src kinases, dasatinib shows multitarget effects, including inhibition of the macrophage colony‐stim

ATP and UTP at low concentrations strong
✍ Astrid Hoebertz; Siva Mahendran; Geoffrey Burnstock; Timothy R. Arnett πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 167 KB

There is increasing evidence that extracellular nucleotides act on bone cells via multiple P2 receptors. The naturally-occurring ligand ATP is a potent agonist at all receptor subtypes, whereas ADP and UTP only act at specific receptor subtypes. We have reported that the formation and resorptive act